AlphaFold predicted structure
DPM3 · Q9P2X0

Mean pLDDT
88.9/ 100
Confident
92 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)35%
- Low(50–70)1%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalCongenital muscular dystrophy
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLimb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
DPM3-congenital disorder of glycosylation
muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15
congenital disorder of glycosylation type I
dengue disease
congenital disorder of glycosylation
neurodegenerative disease
cardiomyopathy
myopathy
EMG: myopathic abnormalities
retinitis pigmentosa
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dolichol-phosphate mannosyltransferase subunit 3
Stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex; tethers catalytic subunit DPM1 to the endoplasmic reticulum
DPM3 · Q9P2X0

Mean pLDDT
88.9/ 100
Confident
92 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0